Where can resmetirom be purchased?

Resmetirom - Rezdiffra is an innovative drug that has received widespread attention in recent years. It is mainly used to treat non-alcoholic steatohepatitis (NASH) and patients with moderate to severe liver fibrosis. As the prevalence of NASH continues to increase worldwide, the market demand for this drug will also expand. However, in China, Resmetirol has not yet completed the formal marketing process and has not been included in the scope of medical insurance reimbursement. Therefore, if patients want to obtain the drug, they often need to purchase it through overseas channels or cross-border medical resources.

In the United States, Resimeterol has been marketed by the original pharmaceutical company under the trade name. The specifications include three packages of 60 mg 30 tablets, 80 mg 30 tablets and 100 mg*30 tablets. It is mainly provided to qualified patients by regular pharmacies and specific medical institutions. Since this drug is a prescription drug, it must be purchased under the guidance of a doctor's evaluation and prescription, and cannot be obtained freely through ordinary retail channels. At the same time, some international pharmacies or cross-border drug service platforms will also provide ordering services for original drugs, but a doctor's prescription is still required to ensure rational drug use and safety.

As for the generic versions, there are currently ASEAN and Lucius versions circulating in Southeast Asian countries such as Laos. The active ingredients of these generic drugs are consistent with the original drugs and can meet certain clinical needs. Some patients will obtain such generic drugs through cross-border drug purchase channels. However, due to differences in drug regulatory standards in different regions, drug quality, packaging and instructions may be different. Therefore, it is recommended that patients screen and select under the guidance of professional doctors to avoid affecting the treatment effect due to unknown sources of drugs.

Reference materials:https://www.drugs.com/monograph/resmetirom.html